Kevin W Lobdell MD
Adult Cardiac Surgery, Pediatric Cardiac Surgery, Trauma Surgery & Surgical Critical Care
System & Fellowship Program Director Sanger Heart & Vascular Institute Professor Wake Forest University School of Medicine Advocate Health
Join to view full profile
1025 Morehead Medical DrSte 300Charlotte, NC 28204
Phone+1 704-355-1813
Dr. Lobdell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Kevin W. Lobdell MD is a cardiothoracic surgeon @ Sanger Heart & Vascular Institute. He has been in practice 31 years and specializes in acquired and congenital cardiac surgery + cardiac critical care. Additional interests include digital health, quality, safety, optimal human performance, education, & research. Dr. Lobdell serves as reviewer, editor, and board member for various institutions.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Surgical Critical Care, 2003 - 2004
University of Pennsylvania/Children's Hospital of PhiladelphiaFellowship, Congenital Cardiac Surgery, 1994 - 1995
Yale-New Haven Medical CenterResidency, Thoracic Surgery - Integrated, 1992 - 1994- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1991 - 1992
University of MinnesotaResidency, Surgery, 1986 - 1991
Certifications & Licensure
NC State Medical License 2004 - 2027
MI State Medical License 1995 - 2005
PA State Medical License 1994 - 1994
MN State Medical License 1990 - 1993
American Board of Surgery Surgical Critical Care
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Preemptive transvalvular mechanical circulatory support is safe and feasible in high-risk cardiac surgery patients: Results of Impella-Protected Cardiac Surgery Trial.Daniel J Goldstein, Edward G Soltesz, George Batsides, Jay K Bhama, Amit A Pawale
The Journal of Thoracic and Cardiovascular Surgery. 2026-08-22 - 1 citationsDesign and rationale of the Impella®-protected cardiac surgery trial (IMPACT): A multicenter, single-arm pilot study in high-risk cardiac surgery patients.Daniel J Goldstein, Hermann Reichenspurner, Esther Vorovich, Jeffrey Teuteberg, Danny Ramzy
American Heart Journal. 2026-07-01 - From fast track to ultrafast track extubation in cardiac surgery: a systematic review.Simona Silvetti, Stefano Fresilli, Domenico Abelardo, Valentina Ajello, Tommaso Aloisio
Minerva Anestesiologica. 2026-06-01
Authored Content
- Toronto, Technology, & Enhancing Recovery After Cardiac Surgery: AATS 2024May 2024
- A 'Once-in-a-Century' Opportunity to Improve Health CareMay 2023
- AATS 2022: Sharing Our VictoriesMay 2022
Press Mentions
Medical: Heart HealthMay 31st, 2025- One of Hospitals' Most Profitable Procedures Has a Hidden CostMay 13th, 2025
- How One Health System Reduced Lengths of Stay, Slashed Readmissions After Heart SurgeryDecember 13th, 2024
Grant Support
- LEAD HealthThe Duke Endowment2019–2023
Professional Memberships
- Member
- Member
- ERAS CardiacExecutive Board & Treasurer
- Southern Thoracic Surgical SocietyMember
- European Association of Cardiothoracic SurgeryMember
Industry Relationships
- Steering Committee, AbiomedSteering Committee for research on temporary VADs.2020 - Present
- Independent Quality Consultant, MedtronicIndependent Quality Panel-Structural Heart Independent Quality Reviewer-Valve Trials2014 - Present
- Independent Advisor, Abbott Nutrition International2019 - 2021
External Links
- LinkedInhttp://LinkedIn.com/kevinwlobdell
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: